Back to Mobile View

vaccine

During the H1N1 swine flu pandemic, much criticism was leveled at World Health Organization officials, accusing their response of being too heavily influenced by the pharmaceutical industry. But according to a panel of independent experts, that wasn't the case.
Vaccine makers such as Pfizer are breathing easier now that the Supreme Court has ruled they can't be sued for defective vaccine designs. The majority opinion by Justice Antonin Scalia was unequivocal: Congress has barred lawsuits over the rare but unavoidable side effects of vital vaccines.
Aside from the embarrassment, researchers know deceptions like the autism research fraud can have much larger consequences, both for the parents of autistic children and for the future of their studies. Says one prominent scientist: "It taints a lot of very good work that goes on."
Having an autistic child can present seemingly nonstop challenges for families. Among those are thousands of dollars spent in the hopes, fleeting as they may be, of finding a cure for the exasperating illness. And lining up a qualified doctor can be a full-time job.
As part of its efforts to expand into the biotech market, Johnson & Johnson is making a long-anticipated bid for Dutch vaccine maker Crucell -- in spite of Crucell's recent manufacturing troubles.
The results of a late-stage trial show Menveo could offer protection against meningitis -- an infection of the brain and spinal cord. Now, the drugmaker intends to file Menveo for use in infants in the U.S. and Europe.
It's an important question because 5,000 potential lawsuits alleging that vaccines caused autism lurk in the background, and vaccine makers threaten to stop producing the drugs if the suits are allowed.
Still in hot water over its "phantom recall" of a Motrin product, Johnson & Johnson looks to expand its share of the vaccine market with purchase of Dutch pharma company Crucell.
The World Health Organization has granted prequalification to Pfizer's Prevnar 13 pediatric vaccine, which protects against an array of pneumococcal diseases, the world's leading cause of vaccine-preventable death in children under 5. Pfizer's shares rose more than 1% Monday.
U.S. researchers have discovered two powerful antibodies that can neutralize more than 90% of all known strains of the HIV virus in the lab, according to new research by National Institutes of Health scientists. And another new study has possibly discovered a vaginal gel that can block transmission...

Market Movers

SymbolLastChange / %Volume

Most Actives

BAC
Bank of America Corp
8.10-0.09
-1.04%
149.19M
ALU
Alcatel-Lucent (ADR)
2.20+0.26
+13.40%
94.27M
PBR
Petroleo Brasileiro S.A. (ADR)
29.60-2.39
-7.47%
23.82M
GE
General Electric Company
18.92-0.22
-1.12%
23.49M

% Gainers

CIE
Cobalt International Energy
32.67 +8.77
+36.69%
13.67M
LNKD
LinkedIn Corp.
88.72 +12.33
+16.14%
8.26M
ALU
Alcatel-Lucent (ADR)
2.20 +0.26
+13.40%
94.27M
WNS
WNS (Holdings) Limited (ADR)
10.56 +1.16
+12.34%
2.64M

% Losers

KV-B
K-V Pharmaceutical Co. Class B
2.16-0.47
-17.87%
3,679
KV-A
K V Pharmaceutical Co. Class A
2.17-0.44
-16.86%
1.06M
NBG-A
National Bank of Greece SA (ADR)
5.71-1.04
-15.41%
79,114
OC-B
Owens Corning (Warrant) 'B'
2.27-0.38
-14.34%
12,194
Newswire

Follow Us

Headlines From DailyFinance Partners

CNN Money
CNBC
Smart Money
Consumer Reports
Huffington Post
AOL Energy
AOL Jobs
Business News Personal Finance Investing Our Partners

DailyFinance Sitemap | Terms of Service | Privacy Policy | Trademarks | HELP | Advertise With Us

© Copyright 2012 AOL Inc. All Rights Reserved